Radient Technologies (Radient Technologies) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies ROE % Adjusted to Book Value?

Radient Technologies's ROE % for the quarter that ended in Dec. 2022 was 0.00%. Radient Technologies's PB Ratio for the quarter that ended in Dec. 2022 was N/A. Radient Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 was N/A.

Radient Technologies ROE % Adjusted to Book Value Historical Data

The historical data trend for Radient Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies ROE % Adjusted to Book Value Chart

Radient Technologies Annual Data

Trend

Dec13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.28

-13.15

-38.30

Radient Technologies Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Radient Technologies's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Radient Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radient Technologies's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radient Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Radient Technologies's ROE % Adjusted to Book Value falls into.

Radient Technologies ROE % Adjusted to Book Value Calculation

Radient Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Radient Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Radient Technologies ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Radient Technologies's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Radient Technologies (Radient Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4

Website

https://www.radientinc.com

Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.